- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Empagliflozin with linagliptin – March 2017
Empagliflozin with linagliptin: Tablet containing 10 mg empagliflozin with 5 mg linagliptin; Tablet containing 25 mg empagliflozin with 5 mg linagliptin; Glyxambi®
Last updated
14 July 2017